Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat

Brain Research

Volumn 812, Issue 1-2, 1998, Pages 113-120

  Amat, Jose ^a   Matus Amat, Patricia ^b   Watkins, Linda R ^c   Maier, Steven F ^c  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

5 HIAA; 5 HT; Amygdala; In vivo microdialysis; Inescapable shock; Learned helplessness; Stressor controllability

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; ELECTRIC SHOCK; HELPLESSNESS; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, OPERANT; ELECTROSHOCK; ESCAPE REACTION; HYDROXYINDOLEACETIC ACID; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STRESS;

EID: 0032561732     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00960-3     Document Type: Article

References (59)

1. Adell A., Casanovas J.M., Artigas F. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology. 36:1997;735-741.
2. J.P. Aggleton, The Amygdala, Wiley, Liss, New York, 1992.
3. Amat J., Matus-Amat P., Watkins L., Maier S.F. Escapable and inescapable stress differentially and selectively alter extracellular levels of 5-HT in the ventral hippocampus and dorsal periaqueductal gray of the rat. Brain Res. 797:1998;12-22.
4. H. Anisman, S. Zalcman, N. Shanks, R.M. Zacharko, Multisystem regulation of performance deficits induced by stressors. An animal model of depression, in: A. Boulton, G. Baker, M.T. Martin Iverson (Eds.), Animal models in psychiatry II, Humana Press, Clifton, NJ, 1991, pp. 1-61.
5. Applegate C.D., Kapp B.S., Underwood M.D., McNall C.L. Autonomic and somatomotor effects of amygdala central n. stimulation in awake rabbits. Physiol. Behav. 31:1983;353-360.
6. 3 receptor antagonist, in two animal models of anxiety. Eur. J. Pharmacol. 218:1992;327-334.
7. Blanchard D.C., Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol. 81:1972;281-290.
8. Campeau S., Hayward M.D., Hope B.T., Rosen J.B., Nestler E.J., Davis M. Induction of c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res. 565:1991;349-352.
9. 1A binding in rat brain: a combined in situ hybridization and in vitro receptor autoradiography study. Brain Res. 561:1991;51-60.
10. Crespi F., Garratt J.C., Sleight A.J., Marsden C.A. In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism. Neuroscience. 35:1990;139-144.
11. Davis M. The role of the amygdala in fear and anxiety. Ann. Rev. Neurosci. 15:1992;353-375.
12. Davis M., Cassella J.V., Kehne J.H. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology. 94:1988;14-20.
13. Dunn J.D., Whitener J. Plasma corticosterone responses to electrical stimulation of the amygdaloid complex: cytoarchitectural specificity. Neuroendocrinology. 42:1986;211-217.
14. Duxon M.S., Flanigan T.P., Reavley A.C., Baxter G.S., Blackburn T.P., Fone K.C. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience. 76:1997;323-329.
15. M.S. Fanselow, L.S. Lester, A functional behavioristic approach to aversively motivated behavior: Predatory imminence as a determinant of the topography of defensive behavior, in: R.C. Bolles, M.D. Beecher (Eds.), Evolution and learning, Erlbaum, Hillsdale, NJ, 1988, pp. 185-212.
16. 1A-receptor ligands in dorsal raphé and ventral hippocampus. Pharmacol. Biochem. Behav. 54:1996;123-128.
17. File S.E., Hyde J.R.G., Macleod N.K. 5.7-Dihydroxytryptamine lesions of dorsal and median raphe nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J. Affect. Disorders. 1:1979;115-122.
18. Goldstein L.E., Rasmusson A.M., Bunney B.S., Roth R.H. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J. Neurosci. 16:1996;4787-4798.
19. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res. 732:1996;145-153.
20. Graeff F.G., Guimarães F.S., De Andrade T.G.C.S., Deakin J.F.W. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. 54:1996;129-141.
21. Graeff F.G., Silveira M.C.L., Nogueira R.L., Audi E.A., de Oliveira R.M.W. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav. Brain. Res. 58:1993;123-131.
22. Grahn R.E., Maier S.F. The elevated plus-maze is not sensitive to the effects of stressor controllability in rats. Pharmacol. Biochem. Behav. 52:1995;565-570.
23. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models in anxiety disorders: more than 30 years of research. Pharmacol. Ther. 65:1995;319-395.
24. 3 receptor antagonists. Psychopharmacology. 104:1991;545-551.
25. 1-like and GABA receptors in the dorsal raphé nucleus of the rat. Neuropharmacology. 27:1988;993-1001.
26. 1A receptor agonists in two models of anxiety after dorsal raphé injection. Psychopharmacology. 106:1992;261-267.
27. Hitchcock J.M., Davis M. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm. Behav. Neurosci. 100:1986;11-22.
28. Hodges H., Green S., Glenn B. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology. 92:1987;491-504.
29. Hogg S., Andrews N., File S.E. Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology. 33:1994;343-348.
30. Jones B.J., Paterson I.A., Roberts M.H.T. Microinjections of methyl-β-carboline-3-carboxylate into the dorsal raphé nucleus: Behavioral consequences. Pharmacol. Biochem. Behav. 24:1986;1487-1489.
31. Kapp B.S., Frysinger R.C., Gallagher M., Haselton J.R. Amygdala central nucleus lesions: Effects on heart rate conditioning in the rabbit. Physiol. Behav. 23:1979;1109-1117.
32. Kawahara H., Yoshida M., Yokoo H., Nishi M., Tanaka M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci. Lett. 162:1993;81-84.
33. Kirby L.G., Allen A.R., Lucki I. Regional differences in the effects of forced swimming and extracellular levels of 5-HT and 5-HIAA. Brain Res. 682:1995;189-196.
34. Kirby L.G., Chou-Green J.M., Davis K., Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 682:1997;189-196.
35. LeDoux J.E. Emotional memory: in search of systems and synapses. Ann. NY Acad. Sci. 702:1993;149-157.
36. Ma Q.T., Yin G.F., Ai M.K., Han J.S. Serotonergic projections from the nucleus raphe dorsalis to the amygdala in the rat. Neurosci. Lett. 134:1991;21-24.
37. S.F. Maier, Learned helplessness, fear and anxiety, in: C. Stanford, P. Salmon (Eds.), Stress: From synapse to syndrome, Academic Press, San Diego, CA, 1993, pp. 207-248.
38. Maier S.F. The role of fear in mediating the shuttle escape learning deficit produced by inescapable shock. JEP: Anim. Behav. Proc. 16:1990;137-150.
39. Maier S.F., Busch C., Maswood S., Grahn R.E., Watkins L.R. The dorsal raphe nucleus is a site of action mediating the behavioral effects of the benzodiazepine receptor inverse agonist DMCM. Behav. Neurosci. 109:1995;759-766.
40. Maier S.F., Grahn R.E., Kalman B.A., Sutton L.C., Wiertelak E.P., Watkins L.R. The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock. Behav. Neurosci. 107:1993;377-388.
41. Maier S.F., Grahn R.E., Maswood S., Watkins L.R. The benzodiazepine receptor antagonists flumazenil and CGS8216 block the enhancement of fear conditioning and interference with escape behavior produced by inescapable shock. Psychopharmacology. 121:1995;250-258.
42. Maier S.F., Grahn R.E., Watkins L.R. 8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhanced fear conditioning and the interference with escape produced by exposure to inescapable shock. Behav. Neurosci. 109:1995;404-412.
43. Maier S.F., Jackson R.L. The nature of the initial coping response and the learned helplessness effect. Anim. Learn. Behav. 5:1977;407-414.
44. Maier S.F., Kalman B.A., Grahn R.E. Chlordiazepoxide microinjected into the region of the dorsal raphe nucleus eliminates the interference with escape responding produced by inescapable shock whether administered before inescapable shock or escape testing. Behav. Neurosci. 108:1994;121-130.
45. Maier S.F., Seligman M.E.P. Learned helplessness: theory and evidence. JEP: Gen. 105:1976;3-46.
46. Morin L.P., Marchant E.G., Meyer-Bernstein E.L. Distribution of Fos immunoreactivity in response to raphe stimulation. Soc. Neurosci. Abst. 27:1997;1219.
47. Overmier J.B., Seligman M.E.P. Effects of inescapable shock on subsequent escape and avoidance behavior. J. Comp. Physiol. Psychol. 63:1967;23-33.
48. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, 2nd edn., Academic Press, San Diego, CA, 1986.
49. Petty F., Kramer G., Wilson L. In vivo serotonin released and learned helplessness. Psychiat. Res. 52:1994;285-293.
50. Roozendaal B., Koolhaas J.M., Bohus B. Attenuated cardiovascular, neuroendocrine, and behavioral responses after a single footshock in central amygdaloid lesioned male rats. Physiol. Behav. 50:1991;771-775.
51. Rueter L.E., Jacobs B.L. A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations. Brain Res. 739:1996;57-69.
52. 1A-receptor agonists 8-OH-DPAT, ipsapirone and busiprone in the rat. Eur. J. Pharmacol. 249:1993;341-351.
53. Sharp T., Bramwell S.R., Clark D., Grahame-Smith D.G. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: Changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 53:1989;234-240.
54. Short K.R., Maier S.F. Stressor controllability social interaction and benzodiazepine systems. Pharmacol. Biochem. Behav. 45:1993;1-9.
55. Viana M.B., Graeff F.G., Löschmann P.-A. Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray. Pharmacol. Biochem. Behav. 58:1997;167-172.
56. 4 binding sites in rodent brain. Neuropharmacology. 33:1994;527-541.
57. Weiss J.M., Goodman P.A., Losito B.G., Corrigan S., Charry J.M., Bailey W.H. Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res. 3:1981;167-205.
58. Wolf W.A., Kuhn D.M. Uptake and release of tryptophan and serotonin: an HPLC method to study the flux of endogenous 5-hydroxyindoles through synaptosomes. J. Neurochem. 46:1986;61-67.
59. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.